The Food and Drug Administration announced it is shutting down its controversial "alternative summary reporting" program and ending its decades-long practice of allowing medical device makers to conceal millions of reports ...
May 06, 2019
0
0
A team of researchers from the Department of Energy's Oak Ridge National Laboratory Health Data Sciences Institute has harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
Mar 11, 2019
0
5
Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system.
Nov 27, 2018
0
39
When assessing the effects of socioeconomic status (SES) on health inequalities or outcomes of care, it is worthwhile to use small-area-based open data instead of individual SES information, according to a new study from ...
Nov 27, 2018
0
0
The selection of a first-line chemotherapy drug to treat many types of cancer is often a clear-cut decision governed by standard-of-care protocols, but what drug should be used next if the first one fails?
Nov 07, 2018
0
90
Scientists at UC San Francisco have painstakingly assembled a searchable database of normal human immunity that researchers can now use as an instant comparison group in studies of the immune system and immune dysfunction. ...
Oct 09, 2018
0
3
The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. ...
Aug 05, 2017
0
41
A systematic review of rodent studies of anxiety drug targets has found a possible reason for thwarted drug development in the field: researchers might not reveal all the data they collect.
Nov 30, 2016
0
0
Analyzing page views of Wikipedia articles could make it possible to monitor and forecast diseases around the globe, according to research publishing this week in PLOS Computational Biology.
Nov 13, 2014
0
0
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases (NTDs), through ...
Nov 13, 2012
0
0
